FDA Used Incomplete Data To Justify Deregulation of Chemical Abortion Pills, Studies Show

The Food and Drug Administration relied on incomplete data to reach its determination that it is safe to deregulate chemical abortion pills, according to medical studies.

FDA officials brushed aside concerns that women who obtain chemical abortion pills without an in-person doctor visit might put their health at risk.

The reporting system relies on data submitted by the makers of chemical abortion pills, who in turn gather data from doctors who prescribe the drugs.

Efforts to deregulate chemical abortion pills gained traction this year as states across the country passed the most abortion restrictions in a single year since the monumental Roe v. Wade decision.

Plan C, a website that details how to purchase black-market chemical abortion pills online, said it had a significant increase in traffic in Texas after the state enacted its six-week abortion ban.

Advocates of mifepristone deregulation cite studies that show rates of adverse events at well below one percent, but these studies also rely on data from the drug's distributors.

Studnicki says the abortion lobby has leveraged its ties to the Democratic Party to elide the dangers of chemical abortion pills.

https://freebeacon.com/policy/fda-used-incomplete-data-to-justify-deregulation-of-chemical-abortion-pills-studies-show/